About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDNANCT02552732

Nasal High Flow Therapy 30 Day Readmission Study

The aim of this feasibility study is to provide data for a subsequent randomized controlled trial to investigate if patient outcomes will be improved after an acute COPD exacerbation using domiciliary...

Lead sponsor: Fisher and Paykel Healthcare•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Fisher and Paykel Healthcare

Collaborators

Medical Research Institute of New Zealand
Alana Healthcare

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•18 years of age or older
•Male and female
•Admitted to the respiratory ward(s) of either recruiting hospitals with AECOPD as the primary diagnostic reason for admission.

Exclusion Criteria

•Given a new home oxygen therapy prescription during the current hospital admission
•The investigator believes the participant or their care giver will be unable to safely use the myAIRVO 2 device following discharge
•They have any other condition which, at the investigator's discretion, is believed may present a safety risk or impact the feasibility of the study or the study results

Related studies

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

RECRUITINGPhase 3

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

NCT07190209 · Chronic Obstructive Pulmonary Disease

Study of Patient With Frequent Exacerbations in Moscow

NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease and Asthma in Workers at Navanakorn Industrial Zone, Thailand

NCT07383896 · Asthma, COPD

RECRUITINGPhase 4

A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation

NCT07073950 · Chronic Obstructive Pulmonary Disease, Hyperinflation

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 17, 2020Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment29

Start dateNov 2015

Last updatedAug 17, 2020

Condition

Chronic Obstructive Pulmonary Disease COPD

Locations shown

Alana HealthCare

Liverpool, New York

Medical Research Institute of New Zealand

Wellington

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 17, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions